newsletter3

banner-about

Programme

Preliminary Agenda:

New Horizons in Emergency Department Assessments

Tuesday 2nd June 2015

10:15 – 10:40 Meeting introduction – Prof. Dr. Maaret Castrén

Prognostic Triage Parameters in the Emergency Room
10:40 – 11:00 Why adding a prognostic parameter to Emergency Triage makes sense, Dr. J. Eugen-Olsen (Hvidovre, Denmark)
11:00 – 11:20 suPAR implementation at Hvidovre University Hospital, MD Line Jee Hartmann Rasmussen (Hvidovre, Denmark)
11:20 – 11:40 suPAR - A Prognostic Biomarker in Emergency Medicine, MD Rebecca Monett Østervig, (Hillerød, Denmark)
11:40 - 12:00 suPAR Associated with Prognosis for Cardiovascular Mortality and MI, MD Gethin Hodges (Glostrup, Denmark)
12:00 – 12:30 Geriatric Patients and Vitality Parameters in combination with prognostic suPAR testing at Hvidovre Hospital Denmark, Dr. J. Eugen-Olsen (Hvidovre, Denmark)

12:30 – 13:30 Lunch Break, Posters, MysuPAR workshop – Get your own suPAR Level tested

Pre-hospital suPAR Risk Prognosis
13:30 – 13:50 suPAR and lactate for identification of critical illness in patients presenting with unspecific symptoms in the pre-hospital setting - the PRIUS-project, RN 
CRNA Robert Ivic (Karolinska, Sweden) 

Economic Impacts of suPAR Implementations in the Emergency Department
13:50 – 14:05 Health Economic Evaluation of suPAR testing, CEO Jakob Knudsen (ViroGates Denmark)
14:05 – 14:20 New suPARnostic test for pre-hospital use, VP Helle Fisker (ViroGates, Denmark)

Risk Prognosis in Selected Diseases and in the General Population
14:20 – 14:40 Adding a prognostic biomarker til other assesments of the patients arriving with Dyspnea, MD Klas Gränsbo (Malmö, Sweden)
14:40 – 15:00 Monitoring of life style changes in a general population cohort, MD Thomas Huneck Haupt (Hvidovre, Denmark)

15:00 – 15:20 Coffee/Tea break

15:20 – 15:40 suPAR in children with pneumonia, Dr. August Wrotek (Warzaw, Poland)
15:40 – 16:00 Debate – Which patients groups in the ED would benefit the most of having their suPAR level measured?

16:00 Closing remarks – Prof. Dr. Maaret Castrén

Cheers and departure

Contact us

virogates logo2
Blokken 45

3460 Birkerød
Denmark

Phone +45 21 13 13 36
Skype: virogates
CVR No.: 25734033
E-mail: info@virogates.com

 in-2  tw-2